RxRevu picks up $7m Series B
RxRevu, a Denver-based prescription pricing company, has secured $7 million in Series B funding.
RxRevu, a Denver-based prescription pricing company, has secured $7 million in Series B funding.
Copyright PEI Media
Not for publication, email or dissemination
